Evidence map›Paper›PMID 42865390›Full record

ArticleFrontiers in endocrinology2026

Reproductive outcomes after expectant management and 5- versus 15-minute laparoscopic ethanol sclerotherapy for ovarian endometriomas: a retrospective cohort study.

Yutong Wang, Qunxian Rao, Zhi Zeng, Manchao Li, Rang Liu, Rui Xiang, Feng Wang, Weifen Deng, Xiaoyan Liang, Jintao Peng and 1 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yutong WangReproductive Medicine Research Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Qunxian RaoDepartment of Gynecologic Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Zhi ZengReproductive Medicine Research Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Manchao LiReproductive Medicine Research Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Rang LiuReproductive Medicine Research Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Rui XiangReproductive Medicine Research Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Feng WangFertility Center, Shenzhen Hengsheng Hospital, Shenzhen, Guangdong, China.
Weifen DengFertility Center, Shenzhen Hengsheng Hospital, Shenzhen, Guangdong, China.
Xiaoyan LiangReproductive Medicine Research Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Jintao PengReproductive Medicine Research Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Haitao ZengReproductive Medicine Research Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Laparoscopic ethanol sclerotherapy is a fertility-preserving alternative for ovarian endometriomas, but the appropriate ethanol exposure duration remains uncertain. We compared expectant management with 5- and 15-minute ethanol retention protocols. Methods: This retrospective cohort study included 333 infertile women with ovarian endometriomas ≥4 cm and complete cumulative reproductive follow-up: expectant management (n=125), 5-minute (n=124), or 15-minute (n=84) laparoscopic ethanol sclerotherapy. Multinomial propensity scores and inverse probability of treatment weighting (IPTW) balanced prespecified baseline covariates. The primary outcome was complete cumulative live birth; secondary outcomes included cumulative clinical pregnancy, embryological outcomes, and serum AMH changes. Additional sensitivity analyses examined FSH and adenomyosis, calendar year, male factor, and an analysis retaining all 357 clinically eligible women. Results: After primary weighting, all prespecified covariates were balanced (maximum absolute standardized mean difference, 0.094). Cumulative clinical pregnancy rates were 48.4%, 78.2%, and 58.1%, and cumulative live birth rates were 42.7%, 73.0%, and 50.8% in the expectant, 5-minute, and 15-minute groups, respectively (both overall P<0.001). Compared with expectant management, the 5-minute protocol was associated with higher odds of clinical pregnancy (OR = 3.84, 95% CI 1.86-7.93; P<0.001) and live birth (OR = 3.63, 95% CI 1.80-7.30; P<0.001), and with higher odds than the 15-minute protocol (OR = 2.60, 95% CI 1.13-6.00; P = 0.020; and OR = 2.62, 95% CI 1.18-5.81; P = 0.013). The 15-minute protocol did not differ significantly from expectant management. Doubly robust analyses were consistent. In the expanded sensitivity analyses and the additional sensitivity analysis retaining all 357 clinically eligible women, the direction of the primary outcome associations was also unchanged. The proportion of cycles yielding no transferable embryo was lower in the 5- and 15-minute groups than in the expectant group (10.7% and 9.4% vs. 32.8%; overall P<0.001). The relative AMH decline was greater after the 15-minute than the 5-minute protocol (-23.7% vs. -8.1%; P = 0.003). Conclusions: In this retrospective cohort, the 5-minute protocol was associated with higher cumulative pregnancy and live birth rates than expectant management and the 15-minute protocol. Both protocols were associated with fewer cycles yielding no transferable embryo than expectant management, whereas 15-minute retention was associated with a greater AMH decline. These findings are hypothesis-generating and require prospective randomized confirmation.

Indexed as

EndometriosisEthanolInfertility, FemaleLaparoscopyOvarian DiseasesSclerotherapyWatchful WaitingAdultFemaleHumansLive BirthPregnancyPregnancy OutcomePregnancy RateRetrospective StudiesTime FactorsEthanolanti-müllerian hormonecumulative live birthethanol sclerotherapyinverse probability of treatment weightingovarian endometriomaovarian reserve

Identifiers

PMID42865390
PMCPMC13654783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.